Home » Topics » BioWorld Science

BioWorld Science
RSS

Icahn School of Medicine at Mount Sinai patents DYRK1A inhibitors

Jan. 14, 2022

Antibodies against SIRPA and SIRPB1 promote antitumoral effect in preclinical study

Jan. 14, 2022

RBD-PB6 RNA aptamer blocks SARS-CoV-2 entry into host cells

Jan. 14, 2022

Modulation of IL-19 regulates DNA damage-induced cytokine production

Jan. 13, 2022

Hemogenyx and Selexis agree to develop cell line for Hemogenyx's CDX bispecific antibody

Jan. 13, 2022

Immix reports promising response rate with IMX-110 in first-line therapy-resistant STS mouse study

Jan. 13, 2022

Lantern Pharma expands collaboration with NCI to support progression of LP-184 and LP-284

Jan. 13, 2022

Researchers restore front-line antibiotics' effects

Jan. 13, 2022

Alchemedicine discovers CK1 and/or TGFBR1 inhibitors

Jan. 13, 2022

Roche synthesizes new Mat2A inhibitors

Jan. 13, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...